Recurrence pattern and its risk factors in patients with resected pancreatic ductal adenocarcinoma - A retrospective analysis of 272 patients

被引:3
作者
Brunner, Maximilian [1 ]
Flessa, Marteen [1 ]
Jacobsen, Anne [1 ]
Merkel, Susanne [1 ]
Krautz, Christian [1 ]
Weber, Georg F. [1 ]
Gruetzmann, Robert [1 ]
机构
[1] Friedrich Alexander Univ, Dept Gen & Visceral Surg, Krankenhausstr 12, Erlangen, Germany
关键词
Pancreatic ductal adenocarcinoma; Resection; Surgery; Recurrence; Early recurrence; Locoregional recurrence; Overall survival; CANCER STATISTICS; PANCREATICODUODENECTOMY;
D O I
10.1016/j.pan.2024.07.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The aim of this study was to investigate the patterns of recurrence and their associated risk factors in patients who underwent resection for pancreatic carcinoma. Methods: This retrospective study included 272 patients, who underwent Ro/R1-resection of PDAC from 2005 to 2020 at the University Hospital Erlangen. Risk factors for different recurrence patterns and the prognostic value of recurrence pattern on the overall survival after recurrence were evaluated. Results: 61 % of the patients experienced recurrence, mostly within the first 12 postoperative months (62%) and in the form of metastases (87 %). The median overall survival from recurrence was 9.2 months. The preoperative absence of diabetes and the presence of lymph node metastasis were independent risk factors for recurrence and a preoperative CA19-9 exceeding 97 U/ml for early recurrence. Additionally, lymph node metastases were associated with a higher risk of metastatic recurrence. Early recurrence, but not the site of recurrence, was identified as an independent prognostic factor for worse overall survival from recurrence. Conclusion: The occurrence of recurrence and especially of early and metastatic recurrence are associated with a worse overall survival. Patients lacking preoperative diabetes, having high preoperative CA19-9 values and lymph node metastases are particularly at risk for (early) recurrence. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of IAP and EPC. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:930 / 937
页数:8
相关论文
共 19 条
[1]   Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions [J].
Brunner, Maximilian ;
Wu, Zhiyuan ;
Krautz, Christian ;
Pilarsky, Christian ;
Gruetzmann, Robert ;
Weber, Georg F. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
[2]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[3]   Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma [J].
Groot, Vincent P. ;
Gemenetzis, Georgios ;
Blair, Alex B. ;
Ding, Ding ;
Javed, Ammar A. ;
Burkhart, Richard A. ;
Yu, Jun ;
Rinkes, Inne H. Borel ;
Molenaar, I. Quintus ;
Cameron, John L. ;
Fishman, Elliot K. ;
Hruban, Ralph H. ;
Weiss, Matthew J. ;
Wolfgang, Christopher L. ;
He, Jin .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (08) :2475-2483
[4]   Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer [J].
Honselmann, Kim C. ;
Pergolini, Ilaria ;
Fernandez-del Castillo, Carlos ;
Deshpande, Vikram ;
Ting, David ;
Taylor, Martin S. ;
Bolm, Louisa ;
Qadan, Motaz ;
Wellner, Ulrich ;
Sandini, Marta ;
Bausch, Dirk ;
Warshaw, Andrew L. ;
Lillemoe, Keith D. ;
Keck, Tobias ;
Ferrone, Cristina R. .
ANNALS OF SURGERY, 2020, 272 (02) :357-365
[5]   Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer [J].
Imamura, Masafumi ;
Nagayama, Minoru ;
Kyuno, Daisuke ;
Ota, Shigenori ;
Murakami, Takeshi ;
Kimura, Akina ;
Yamaguchi, Hiroshi ;
Kato, Toru ;
Kimura, Yasutoshi ;
Takemasa, Ichiro .
CANCERS, 2021, 13 (10)
[6]   Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial [J].
Jones, Robert P. ;
Psarelli, Eftychia-Eirini ;
Jackson, Richard ;
Ghaneh, Paula ;
Halloran, Christopher M. ;
Palmer, Daniel H. ;
Campbell, Fiona ;
Valle, Juan W. ;
Faluyi, Olusola ;
O'Reilly, Derek A. ;
Cunningham, David ;
Wadsley, Jonathan ;
Darby, Suzanne ;
Meyer, Tim ;
Gillmore, Roopinder ;
Anthoney, Alan ;
Lind, Pehr ;
Glimelius, Bengt ;
Falk, Stephen ;
Izbicki, Jakob R. ;
Middleton, Gary William ;
Cummins, Sebastian ;
Ross, Paul J. ;
Wasan, Harpreet ;
McDonald, Alec ;
Crosby, Tom ;
Ting, Yuk ;
Patel, Kinnari ;
Sherriff, David ;
Soomal, Rubin ;
Borg, David ;
Sothi, Sharmila ;
Hammel, Pascal ;
Lerch, Markus M. ;
Mayerle, Julia ;
Tjaden, Christine ;
Strobel, Oliver ;
Hackert, Thilo ;
Buchler, Markus W. ;
Neoptolemos, John P. ;
Hill, Mark ;
Corrie, Pippa ;
Hickish, Tamas ;
Napier, Mark ;
Slater, Sarah ;
Valle, Juan ;
Shablak, Alaaeldin ;
Cunnell, Michelle ;
Guimbaud, Rosine ;
Roques, Tom .
JAMA SURGERY, 2019, 154 (11) :1038-1048
[7]   Pancreatic cancer [J].
Kamisawa, Terumi ;
Wood, Laura D. ;
Itoi, Takao ;
Takaori, Kyoichi .
LANCET, 2016, 388 (10039) :73-85
[8]   Predictive Nomogram for Early Recurrence after Pancreatectomy in Resectable Pancreatic Cancer: Risk Classification Using Preoperative Clinicopathologic Factors [J].
Kim, Naru ;
Han, In Woong ;
Ryu, Youngju ;
Hwang, Dae Wook ;
Heo, Jin Seok ;
Choi, Dong Wook ;
Shin, Sang Hyun .
CANCERS, 2020, 12 (01)
[9]   Management of isolated recurrence after surgery for pancreatic adenocarcinoma [J].
Kim, Y. I. ;
Song, K. B. ;
Lee, Y. -J. ;
Park, K. -M. ;
Hwang, D. W. ;
Lee, J. H. ;
Shin, S. H. ;
Kwon, J. W. ;
Ro, J. -S. ;
Kim, S. C. .
BRITISH JOURNAL OF SURGERY, 2019, 106 (07) :898-909
[10]   Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma [J].
Kolbeinsson, Hordur ;
Hoppe, Allison ;
Bayat, Aqieda ;
Kogelschatz, Benjamin ;
Mbanugo, Chineze ;
Chung, Mathew ;
Wolf, Andrea ;
Assifi, M. Mura ;
Wright, G. Paul .
SURGERY, 2021, 169 (03) :649-654